Bank of America’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bank of America’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,960	Closed	-$179K	–	8181
2014 Q4	$179K	Sell	2,960 -3,500	-54%	-$176K	﹤0.01%	5448
2014 Q3	$275K	Sell	6,460 -840	-12%	-$45.1K	﹤0.01%	5098
2014 Q2	$451K	Buy	7,300 +6,200	+564%	+$361K	﹤0.01%	4735
2014 Q1	$72K	Sell	1,100 -7,590	-87%	-$513K	﹤0.01%	6219
2013 Q4	$489K	Buy	8,690 +670	+8%	+$37.6K	﹤0.01%	4779
2013 Q3	$492K	Buy	8,020 +260	+3%	+$17.6K	﹤0.01%	4656
2013 Q2	$453K	Buy	+7,760	New	+$477K	﹤0.01%	4857

Other funds holding OREX

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of America's OREX Position: Q2 2018 in Review

Bank of America sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 8,944 shares — an estimated $2K sold.

Bank of America first reported a position in OREX in Q2 2013 and held it in 19 quarters. The position peaked at $21.7M in Q1 2014. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.

Bank of America reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
Bank of America sold 8,944 Orexigen Therapeutics, Inc. shares in Q2 2018, an estimated $2K.
Bank of America first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 19 quarters.
Bank of America's Orexigen Therapeutics, Inc. position peaked at $21.7M in Q1 2014.
4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.

Based on Bank of America's 13F filing for Q2 2018, filed 14 Aug 2018.